WuXi PharmaTech (WX) Approves $30M Common Buyback

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), has approved a share repurchase plan. Under this plan, the Company is authorized to repurchase up to $30 million of its American Depositary Shares, or ADSs, over the next eighteen months, from time to time, in open-market purchases on the NYSE Euronext at prevailing market prices, in trades pursuant to a Rule 10b5-1 repurchase plan, or otherwise, in accordance with applicable federal securities laws, including the anti-manipulation provisions of Rule 10b-18, promulgated under the U.S. Securities Exchange Act of 1934, as amended.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Reitar Logtech launches $3M share repurchase program
• Universal Music Group repurchases 9.4 million shares under €250M buyback
• Cycurion board approves $500,000 share repurchase program